BackSeneca Biopharma Overview

Seneca Biopharma Current Assets

Seneca Biopharma's current assets is $13M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$12.88M
128.10% YoYΔ $7.23M vs prior year quarter

Peer average / median

Loading

Seneca Biopharma Current Assets History

Loading

Seneca Biopharma vs. peers: Current Assets Comparison

Loading

Seneca Biopharma Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Seneca Biopharma (SNCA) FAQ

As of the most recent data (December 2020), SNCA shows a current assets of $13M. That compares with $5.6M in the prior-year period — up 128.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SNCA's current assets is now $13M (was $5.6M) — a 128.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Seneca Biopharma is outperforming or lagging.

Tracking SNCA's current assets over time shows whether Seneca Biopharma is scaling, shrinking, or reshaping that part of the business. The current reading is $13M That compares with $5.6M in the prior-year period — up 128.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Seneca Biopharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $13M) with ownership activity and broader fundamentals.

Seneca Biopharma's current assets is $13M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.